fucose has been researched along with Liver Dysfunction in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (28.00) | 18.7374 |
| 1990's | 5 (20.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolbach, G; Clodic, G; Housset, C; Huguet, S; Imbert-Bismutd, F; Lubman, DM; Matheron, L; Ngo, Y; Peta, V; Poynard, T; Raluca, P; Rezai, K; Zhu, J | 1 |
| Benicky, J; Goldman, R; Sanda, M; Wei, R; Yuan, W | 1 |
| Bhatia, S; Dalal, B; Dalal, K; Shankarkumar, A; Shukla, A | 1 |
| Bibby, BM; Frisch, K; Keiding, S; Mikkelsen, KS; Sørensen, M; Villadsen, GE | 1 |
| Benicky, J; Goldman, R; Pompach, P; Sanda, M; Wu, J | 1 |
| Block, TM; Mehta, A | 1 |
| Blomme, B; Callewaert, N; Colle, I; Van Steenkiste, C; Van Vlierberghe, H; Vanhuysse, J | 1 |
| Akagi, S; Amano, Y; Hanaoka, T; Ishihara, S; Kinoshita, Y; Miyake, T; Sato, S; Tobita, H | 1 |
| Aoyagi, Y; Suda, T; Tamura, Y | 1 |
| Hasegawa, T; Kinoshita, N; Korekane, H; Matsumoto, A; Miyoshi, E; Taniguchi, N | 1 |
| Balasubramanian, KA; Eapen, CE; Jeyamani, R; Sathish Kumar, N | 1 |
| Mashige, F | 1 |
| Hashida, M; Higuchi, Y; Kawakami, S; Yamashita, F | 1 |
| Danev, I; Koichev, K; Pateva, R; Rusinov, E; Vurbanov, G | 1 |
| Aoyagi, Y | 1 |
| Aoyagi, Y; Asakura, H; Igarashi, K; Isemura, M; Mori, S; Naitoh, A; Suda, T; Suzuki, Y; Yokota, T | 1 |
| Mann, AC; Record, CO; Self, CH; Turner, GA | 1 |
| Chambers, W; Record, CO; Skillen, AW; Thompson, S; Turner, GA | 1 |
| Fedianin, IuP | 1 |
| Aoyagi, Y; Asakura, H; Igarashi, K; Isemura, M; Mori, S; Nomoto, M; Oguro, M; Saitoh, A; Suzuki, Y; Yokota, T | 1 |
| Aoyagi, Y; Ichida, F; Isemura, M; Ozaki, T; Sekine, C; Soga, K; Suzuki, Y | 1 |
| Aoyagi, Y; Ichida, F; Igarashi, K; Isemura, M; Nomoto, M; Sekine, C; Suzuki, Y | 1 |
| Fukui, M; Honna, T; Ishiguro, T; Sakaguchi, H; Tsuchida, Y | 1 |
| Arcilla, MB; Sturgeon, P | 1 |
| el-Sawy, M; Ghanem, MH; Guirgis, FK | 1 |
3 review(s) available for fucose and Liver Dysfunction
| Article | Year |
|---|---|
Fucosylated glycoproteins as markers of liver disease.
Topics: Animals; Carcinoma, Hepatocellular; Fucose; Glycoproteins; Glycosylation; Hepacivirus; Hepatitis B virus; Humans; Immune System; Immunoglobulin G; Liver; Liver Diseases; Liver Neoplasms; Models, Biological; Proteomics | 2008 |
[Urinary free L-fucose (UFC) and urinary sulfated bile acids (U-SBA)].
Topics: Bile Acids and Salts; Biliary Tract Neoplasms; Biomarkers, Tumor; Chromatography, High Pressure Liquid; Clinical Enzyme Tests; Colorimetry; Fucose; Humans; Liver Diseases; Liver Neoplasms; Mass Screening; Pancreatic Neoplasms; Reference Values; Specimen Handling | 2005 |
Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
Topics: alpha-Fetoproteins; Carbohydrate Sequence; Carcinoma, Hepatocellular; Fucose; Humans; Liver Diseases; Liver Neoplasms; Molecular Sequence Data; Neoplasm Proteins; Time Factors | 1995 |
22 other study(ies) available for fucose and Liver Dysfunction
| Article | Year |
|---|---|
Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.
Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fucose; Haptoglobins; Humans; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Retrospective Studies | 2020 |
Quantitative Analysis of Sex-Hormone-Binding Globulin Glycosylation in Liver Diseases by Liquid Chromatography-Mass Spectrometry Parallel Reaction Monitoring.
Topics: Blood Specimen Collection; Carcinoma, Hepatocellular; Chromatography, Liquid; Fucose; Glycosylation; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Protein Isoforms; Sex Hormone-Binding Globulin; Tandem Mass Spectrometry | 2018 |
Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.
Topics: Adult; Biomarkers, Tumor; Blood Proteins; Carcinoma, Hepatocellular; Chromatography, Liquid; Female; Fucose; Glycoproteins; Glycosylation; Haptoglobins; Hepatitis B; Humans; Immunoassay; Lectins; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Proteomics; Tandem Mass Spectrometry | 2019 |
The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease.
Topics: Adult; Aged; Algorithms; Data Interpretation, Statistical; Female; Fucose; Galactose; Humans; Linear Models; Liver Circulation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Diseases; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Veins | 2014 |
Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver disease.
Topics: Amino Acid Sequence; Complement Factor H; Female; Fucose; Hemopexin; Humans; Liver Diseases; Male; Middle Aged | 2014 |
Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans.
Topics: Adult; Aged; Aged, 80 and over; Animals; Bilirubin; Carbohydrate Sequence; Carbon Tetrachloride Poisoning; Carcinoma, Hepatocellular; Common Bile Duct; Female; Fucose; Galactose; Glycosylation; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Hypertension, Portal; Ligation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Diseases; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Middle Aged; Polysaccharides | 2010 |
Clinical significance of the highly sensitive fucosylated fraction of α-fetoprotein in patients with chronic liver disease.
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chi-Square Distribution; Chronic Disease; Female; Fucose; Humans; Immunoassay; Incidence; Japan; Kaplan-Meier Estimate; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prevalence; Prognosis; Proportional Hazards Models; Protein Processing, Post-Translational; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Time Factors | 2011 |
History and recent progress in evaluation of the fucosylated alpha-fetoprotein fraction.
Topics: alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chronic Disease; Fucose; Humans; Immunoassay; Liver Diseases; Liver Neoplasms; Predictive Value of Tests; Prognosis; Protein Processing, Post-Translational; Research Design; Risk Assessment; Risk Factors; Time Factors | 2011 |
Development of an antibody-lectin enzyme immunoassay for fucosylated α-fetoprotein.
Topics: alpha-Fetoproteins; Antibodies; Blood Chemical Analysis; Carbohydrate Sequence; Carcinoma, Hepatocellular; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Fucose; Fucosyltransferases; Glycosylation; Humans; Immunoenzyme Techniques; Lectins; Liver Diseases; Liver Neoplasms; Models, Biological; Predictive Value of Tests | 2012 |
Serum and urinary fucose concentrations in hepatitis B-related cirrhosis and acute liver diseases.
Topics: Acute Disease; Biomarkers; Colorimetry; Fucose; Hepatitis B; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Diseases | 2004 |
The potential role of fucosylated cationic liposome/NFkappaB decoy complexes in the treatment of cytokine-related liver disease.
Topics: Animals; Cations; Cytokines; Endotoxins; Female; Fucose; Gene Transfer Techniques; Genetic Therapy; Kupffer Cells; Liposomes; Liver Diseases; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; NF-kappa B | 2007 |
[Complex study of glycoproteins in liver disease].
Topics: Ceruloplasmin; Cholinesterases; Female; Fucose; Glycoproteins; Haptoglobins; Hexosamines; Humans; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Orosomucoid; Sialic Acids | 1982 |
Highly enhanced fucosylation of alpha-fetoprotein in patients with germ cell tumor.
Topics: Adolescent; Adult; alpha-Fetoproteins; Female; Fucose; Glucose; Hepatitis; Humans; Immunoelectrophoresis, Two-Dimensional; Infant; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Teratoma | 1993 |
Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease.
Topics: Acetylglucosamine; Adult; Aged; Aged, 80 and over; Alcoholism; Female; Fucose; Glycosylation; Haptoglobins; Humans; Liver Diseases; Liver Diseases, Alcoholic; Male; Middle Aged; Monosaccharides | 1994 |
Abnormally fucosylated haptoglobin as a marker for alcoholic liver disease but not excessive alcohol consumption or non-alcoholic liver disease.
Topics: Adult; Aged; Aged, 80 and over; Alcohol Drinking; Biomarkers; Female; Fucose; Haptoglobins; Humans; Liver Diseases; Liver Diseases, Alcoholic; Male; Middle Aged | 1993 |
[Biochemical indices of the activity of chronic process in the liver].
Topics: Adult; Aged; Chronic Disease; Female; Fucose; Glycoproteins; Hepatitis; Hexoses; Humans; Liver; Liver Cirrhosis; Liver Diseases; Male; Middle Aged | 1977 |
The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver.
Topics: Adenoma, Bile Duct; alpha-Fetoproteins; Biomarkers; Carcinoma, Hepatocellular; Diagnosis, Differential; Fucose; Glucosamine; Humans; Liver Diseases; Liver Neoplasms | 1991 |
Fucosylated alpha-fetoprotein as marker of early hepatocellular carcinoma.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Fucose; Humans; Liver Diseases; Liver Neoplasms; Time Factors | 1985 |
The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma.
Topics: alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Fucose; Humans; Liver Diseases; Liver Neoplasms; Longitudinal Studies; Reference Values | 1988 |
The ratio of fucosylation of alpha-fetoprotein in hepatoblastoma.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Diagnosis, Differential; Fucose; Humans; Immunoelectrophoresis; Lectins; Liver Diseases; Liver Neoplasms; Plant Lectins | 1989 |
Le-x, the spurned antigen of the Lewis blood group system.
Topics: ABO Blood-Group System; Absorption; Adenocarcinoma; Amniotic Fluid; Antibody Specificity; Blood; Carbohydrate Metabolism, Inborn Errors; Erythrocytes; Fetus; Fucose; Hemagglutination Inhibition Tests; Hemagglutination Tests; Humans; Immune Sera; Immunologic Techniques; Isoantibodies; Isoantigens; Lewis Blood Group Antigens; Liver; Liver Diseases; Phenotype; Saliva; Tissue Extracts; Umbilical Cord | 1974 |
Serum glycoproteins in schistosomal hepatic fibrosis.
Topics: Adult; Female; Fucose; Glycoproteins; Hexosamines; Hexoses; Humans; Liver Diseases; Male; Middle Aged; Mucoproteins; Neuraminic Acids; Protein Binding; Schistosomiasis | 1973 |